Evidence map›Paper›PMID 37382614›Full record

ArticleEuropean radiology2023

Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas.

Xiaoxue Liu, Qirui Zhang, Jianrui Li, Qiang Xu, Zhizheng Zhuo, Junjie Li, Xian Zhou, Mengjie Lu, Qingqing Zhou, Hao Pan and 6 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06498778 (Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06498778 completednot on this map

Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage

TypeobservationalSponsorJinling Hospital, ChinaRan2021 to 2023Enrolled698ConditionsSpontaneous Intracerebral Hemorrhage
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xiaoxue LiuDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Qirui ZhangDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Jianrui LiDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Qiang XuDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Zhizheng ZhuoDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Junjie LiDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Xian ZhouDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Mengjie LuSchool of Public Health, Shanghai JiaoTong University School of Medicine, Shanghai, 200240, China.
Qingqing ZhouDepartment of Radiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 211100, China.
Hao PanDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, China.
Nan WuDepartment of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, China.
Qing ZhouDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, 200232, China.
Feng ShiDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., Shanghai, 200232, China.
Guangming LuDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China.
Yaou LiuDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Zhiqiang ZhangDepartment of Diagnostic Radiology, Affiliated Jinling Hospital, Medical School of Nanjing University, 305#, Eastern Zhongshan Rd, Nanjing, 210002, China. zhangzq2001@126.com.ORCID http://orcid.org/0000-0002-3993-7330

Funding

the National Key R&D Program of China 2020AAA0109505the National Key Technology (R&D) Program of the Ministry of Science and Technology 2018YFA0701703the National Natural Science Foundation of China 82127806the National Science and Technology Innovation 2030-Major program of "Brain Science and Brain-Like Research" 2022ZD0211800Xuzhou Medical University Open Fund Project XYKF202101
6 · The paper itself

Abstract

objectivesTo assess the value of coordinatized lesion location analysis (CLLA), in empowering ROI-based imaging diagnosis of gliomas by improving accuracy and generalization performances.

methodsIn this retrospective study, pre-operative contrasted T1-weighted and T2-weighted MR images were obtained from patients with gliomas from three centers: Jinling Hospital, Tiantan Hospital, and the Cancer Genome Atlas Program. Based on CLLA and ROI-based radiomic analyses, a fusion location-radiomics model was constructed to predict tumor grades, isocitrate dehydrogenase (IDH) status, and overall survival (OS). An inter-site cross-validation strategy was used for assessing the performances of the fusion model on accuracy and generalization with the value of area under the curve (AUC) and delta accuracy (ACC) (ACC

resultsA total of 679 patients (mean age, 50 years ± 14 [standard deviation]; 388 men) were enrolled. Based on tumor location probabilistic maps, fusion location-radiomics models (averaged AUC values of grade/IDH/OS: 0.756/0.748/0.768) showed the highest accuracy in contrast to radiomics models (0.731/0.686/0.716) and location models (0.706/0.712/0.740). Notably, fusion models ([median Delta ACC: - 0.125, interquartile range: 0.130]) demonstrated improved generalization than that of radiomics model ([- 0.200, 0.195], p = 0.018).

conclusionsCLLA could empower ROI-based radiomics diagnosis of gliomas by improving the accuracy and generalization of the models. CLINICAL RELEVANCE STATEMENT: This study proposed a coordinatized lesion location analysis for glioma diagnosis, which could improve the performances of the conventional ROI-based radiomics model in accuracy and generalization. KEY POINTS: • Using coordinatized lesion location analysis, we mapped anatomic distribution patterns of gliomas with specific pathological and clinical features and constructed glioma prediction models. • We integrated coordinatized lesion location analysis into ROI-based analysis of radiomics to propose new fusion location-radiomics models. • Fusion location-radiomics models, with the advantages of being less influenced by variabilities, improved accuracy, and generalization performances of ROI-based radiomics models on predicting the diagnosis of gliomas.

Indexed as

Brain NeoplasmsGliomaBrainHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMaleMiddle AgedPower, PsychologicalRetrospective StudiesIsocitrate DehydrogenaseGliomaIsocitrate dehydrogenaseMagnetic resonance imagingPrognosisTumor grading

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.